Number of the records: 1
levodopa
SYS d007980 LBL 00000nz--a2200000o--4500 005 20250606212852.8 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D02.092.311.200.480 065 $a D02.455.426.559.389.657.166.175.200.480 065 $a D12.125.072.050.685.400.500 065 $a D12.125.072.050.875.130.500 066 $a 01 $c 03 150 $a levodopa $x AA $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a L-Dopa $2 eng 450 $w v $a L-DOPA $2 slo 550 $7 sllk_us_auth*d004298 $Y Dopamine $w b $a dopamín 550 $7 sllk_us_auth*d000978 $Y Antiparkinson Agents $w P $a antiparkinsoniká 550 $7 sllk_us_auth*d015259 $Y Dopamine Agents $w P $a látky dopamínové 550 $7 sllk_us_auth*d004298 $Y Dopamine $w p $a dopamín 665 $a 75; was see DOPA 1972-74 $2 eng 665 $a Dopa (1966-1974) $2 eng 680 9-
$i The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. $2 eng 750 -2
$a Levodopa $2 eng 980 $x M
Number of the records: 1